Palisade Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Palisade Asset Management, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $133.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$133.1M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 73,622 | $25.9M |
| JNJJOHNSON & JOHNSON | 102,949 | $25.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 79,645 | $21.6M |
| ABTABBOTT LABORATORIES | 205,870 | $21.1M |
| ABBVAbbVie Inc. | 63,609 | $13.8M |
| LLYELI LILLY & Co | 14,418 | $13.3M |
| MRKMerck & Co., Inc. | 35,199 | $4.2M |
| TECHBIO-TECHNE Corp | 55,524 | $2.9M |
| NVSNovartis AG | 16,409 | $2.5M |
| PFEPFIZER INC | 40,835 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 15,679 | $951K |
| MCKMcKesson Corporation | 326 | $282K |
| PMPhilip Morris International Inc | 1,470 | $243K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.